Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ad-hoc News: Baader Bank AG (EQS) +++ BAADER BANK Aktie +4,04%

AMEDISYS Aktie

 >AMEDISYS Aktienkurs 
82 EUR    (Tradegate)
Ask: 82.5 EUR / 73 Stück
Bid: 81.5 EUR / 74 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
AMEDISYS Aktie über LYNX handeln
>AMEDISYS Performance
1 Woche: -3,0%
1 Monat: -1,2%
3 Monate: -5,2%
6 Monate: -5,5%
1 Jahr: -4,4%
laufendes Jahr: -5,5%
>AMEDISYS Aktie
Name:  AMEDISYS INC. DL-,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0234361089 / 915582
Symbol/ Ticker:  ADY (Frankfurt) / AMED (NASDAQ)
Kürzel:  FRA:ADY, ETR:ADY, ADY:GR, NASDAQ:AMED
Index:  -
Webseite:  https://www.amedisys.com/
Marktkapitalisierung:  2780 Mio. EUR
Umsatz:  2046.29 Mio. EUR
EBITDA:  210.76 Mio. EUR
Gewinn je Aktie:  2.046 EUR
Schulden:  390.27 Mio. EUR
Liquide Mittel:  245.97 Mio. EUR
Umsatz-/ Gewinnwachstum:  4.1% / 323.7%
KGV/ KGV lG:  35.03 / 20.7
KUV/ KBV/ PEG:  1.33 / 2.6 / 1.38
Gewinnm./ Eigenkapitalr.:  3.79% / 7.15%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  AMEDISYS
Letzte Datenerhebung:  02.07.25
>AMEDISYS Eigentümer
Aktien: 32.82 Mio. St.
f.h. Aktien: 32.18 Mio. St.
Insider Eigner: 1.96%
Instit. Eigner: 93.04%
>AMEDISYS Peer Group

 
01.07.25 - 17:21
Proposed Medicare payment cut for home health could scuttle UnitedHealth/Amedisys deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.06.25 - 16:00
Here′s Why You Should Retain AMED Stock in Your Portfolio for Now (Zacks)
 
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry....
23.05.25 - 17:30
Are Medical Stocks Lagging Amedisys (AMED) This Year? (Zacks)
 
Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year....
12.05.25 - 19:24
Amedisys edges lower on report DOJ initially rejects remedy in UnitedHealth (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.05.25 - 02:01
Insiderhandel: Chief Accounting Officer verkauft Aktien von Amedisys im Wert von 35904 USD (Insiderkauf)
 
Guidroz, Allyson - Vorstand - Tag der Transaktion: 2025-05-08...
01.05.25 - 23:36
Amedisys gains after announcing new divestiture agreements in UnitedHealth deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.04.25 - 15:00
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise (Zacks)
 
Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care....
24.04.25 - 04:00
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics (Zacks)
 
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
23.04.25 - 23:21
Amedisys Non-GAAP EPS of $1.25 beats by $0.14, revenue of $594.8M misses by $1.69M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.04.25 - 23:18
Amedisys Q1 Profit Increases, Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Amedisys (AMED) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled $61.01......
23.04.25 - 22:48
Amedisys Reports First Quarter 2025 Financial Results (GlobeNewswire EN)
 
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025....
16.04.25 - 17:30
Amedisys (AMED) Earnings Expected to Grow: Should You Buy? (Zacks)
 
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
19.03.25 - 18:00
Here′s Why You Should Retain AMED Stock in Your Portfolio Now (Zacks)
 
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry....
07.03.25 - 01:01
Insiderhandel: Chief Accounting Officer verkauft Aktien von Amedisys im Wert von 187833 USD (Insiderkauf)
 
Guidroz, Allyson - Vorstand - Tag der Transaktion: 2025-03-04...
03.03.25 - 13:45
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises (Zacks)
 
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care....
27.02.25 - 04:45
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
 
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
26.02.25 - 23:00
Amedisys Non-GAAP EPS of $0.96 misses by $0.10, revenue of $598.1M misses by $4.28M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.25 - 22:33
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results (GlobeNewswire EN)
 
BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024....
21.02.25 - 15:12
UnitedHealth Shares Puke As DoJ Launches Medicare Billing Practice Probe (ZeroHedge)
 
UnitedHealth Shares Puke As DoJ Launches Medicare Billing Practice Probe Shares of UnitedHealth Group plunged in premarket trading after a Wall Street Journal report revealed that the Justice Department had launched a civil fraud investigation into the healthcare group's billing practices, specifically examining how it records diagnoses that increase government payments to its Medicare Advantage plans. The probe follows a series of WSJ reports last year that showed Medicare paid UnitedHealth billions for questionable diagnoses. DoJ attorneys recently interviewed medical providers cited in those articles.  This investigation adds to mounting scrutiny of the $460 billion healthcare giant, which is also facing an antitrust probe and a DoJ lawsuit to block its $3.3 billion acquisition of home-health company Amedisys.  UnitedHealth shares tumbled nearly 10% in premarket trading in response to WSJ's report. Shares are down nearly 25% since Luigi Mangione, the 26-year-old accused of killing U...
20.02.25 - 18:33
Amedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or later (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Kasten voll Lügen wird nicht durchs Stadttor gelassen. - Sprichwort China
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!